Context Therapeutics resolves stockholder class action; $850K mootness fee paid by third party

Context Therapeutics Inc.

Delaware court invalidated classified board and for-cause removal provisions from charter.
Third-party service provider agreed to pay $850,000 mootness fee; company did not pay.
Fee paid May 1, 2026; action to close after annual meeting scheduled June 24, 2026.
Stipulated order granted April 30, 2026; court retains jurisdiction only for mootness fee application.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.